AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,969 | -36.8% | 10,606 | -34.8% | 0.00% | -25.0% |
| Q2 2023 | $204,200 | -49.6% | 16,258 | -55.5% | 0.00% | -60.0% |
| Q1 2023 | $404,785 | +83.8% | 36,500 | +102.4% | 0.01% | +66.7% |
| Q4 2022 | $220,195 | +77.6% | 18,034 | +56.0% | 0.01% | +50.0% |
| Q2 2022 | $124,000 | -59.2% | 11,561 | -56.1% | 0.00% | -60.0% |
| Q4 2021 | $304,000 | +88.8% | 26,356 | +56.7% | 0.01% | +42.9% |
| Q3 2021 | $161,000 | +7.3% | 16,819 | +52.2% | 0.01% | +250.0% |
| Q1 2019 | $150,000 | -51.3% | 11,047 | -63.9% | 0.00% | -50.0% |
| Q2 2017 | $308,000 | – | 30,628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 9,029,843 | $89,576,043 | 10.38% |
| Perceptive Advisors | 28,057,456 | $278,329,964 | 6.70% |
| Redmile Group, LLC | 10,595,089 | $105,103,283 | 6.36% |
| STEMPOINT CAPITAL LP | 1,495,047 | $14,830,866 | 4.36% |
| CM Management, LLC | 450,000 | $4,464,000 | 4.10% |
| Avoro Capital Advisors LLC | 27,400,000 | $271,808,000 | 3.62% |
| GREAT POINT PARTNERS LLC | 1,495,500 | $14,835,360 | 2.84% |
| Saturn V Capital Management LP | 713,536 | $7,078,277 | 2.68% |
| AlphaCentric Advisors LLC | 202,500 | $2,008,800 | 1.48% |
| Novo Holdings A/S | 2,500,000 | $24,800,000 | 1.44% |